Schedule 13G ownership disclosure

Lexeo Therapeutics Inc

Common Stock, $0.0001 par value per share · CUSIP: 52886X107

Event date: 2025-10-20

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RA Capital Management, L.P.

    Shares: 5,000,000.00 · Class: 6.9%

  • Peter Kolchinsky

    Shares: 5,000,000.00 · Class: 6.9%

  • Rajeev Shah

    Shares: 5,000,000.00 · Class: 6.9%

  • RA Capital Healthcare Fund, L.P.

    Shares: 5,000,000.00 · Class: 6.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001346824-25-000027
Form type
SCHEDULE 13G
Filer
Lexeo Therapeutics, Inc.
CIK
CIK 1907108
Filed
Oct 27, 2025
Reporting period
Oct 20, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub